SCHEMBL3432490

SCHEMBL3432490

CCC=CNc1cccc(C)c1C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.45
▸ FABP3 P05413 1/20 0.44
▸ FABP4 P15090 1/20 0.44
▸ TRPM4 Q8TD43 1/20 0.42
▸ RAB9A P51151 3/20 0.41
▸ EGFR P00533 1/20 0.40
▸ MMP1 P03956 1/20 0.40
▸ MMP2 P08253 1/20 0.40
▸ MMP9 P14780 1/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ TDP1 Q9NUW8 2/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ HPGD P15428 3/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ MEN1 O00255 3/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ GPR52 Q9Y2T5 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ DHODH Q02127 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3432487 1.00 KDM4E (0.45) KDM4EFABP3FABP4TRPM4RAB9A
SCHEMBL13880845 0.77 RECQL (0.47) RAB9AL3MBTL1HPGDNPC1MEN1
SCHEMBL1903512 0.76 KDM4E (0.50) KDM4EFABP3FABP4TRPM4RAB9A
SCHEMBL16318050 0.73 KDM4E (0.54) KDM4EFABP3FABP4TRPM4RAB9A
SCHEMBL11923473 0.73 TRPM4 (0.58) KDM4EFABP3FABP4TRPM4RAB9A
SCHEMBL8009873 0.72 KDM4E (0.54) KDM4EFABP3FABP4TRPM4L3MBTL1
SCHEMBL4607469 0.71 KDM4E (0.49) KDM4EFABP3FABP4TRPM4RAB9A
SCHEMBL10489654 0.71 ALDH1A1 (0.57) KDM4ETRPM4RAB9AHPGDNPC1
SCHEMBL6497268 0.71 ITGB3 (0.53) KDM4EFABP3FABP4TRPM4MEN1
SCHEMBL2624008 0.70 HPGD (0.63) KDM4EFABP3FABP4TRPM4RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010063802-A1 3, 4-DI-SUBSTITUTED CYCLOBUTENE- 1, 2 -DIONES AS CXCR2 RECEPTOR ANTAGONISTS NOVARTIS AG (CH) 2010-06-10 — — WO disclosed
Send feedback